A. E. Wro´blewski, D. G. Piotrowska / Tetrahedron: Asymmetry 12 (2001) 2977–2984
2983
acid (0.377 g, 2.92 mmol), DCC (0.637 g, 2.92 mmol)
4.9. Racemisation of (S)-6
and DMAP (0.037 g, 0.29 mmol). After stirring the
mixture for 24 h at room temperature, DCU was
filtered off. After concentration the residue was twice
purified on silica gel with ethyl acetate–hexanes (2:1,
v/v) to give less polar benzoate (1R,2S)-15 (1.03 g),
unreacted phosphonate (1S,2S)-10 (0.202 g, 7%) and
the phosphonate 10 contaminated with minute quanti-
ties of unidentified organophosphorus compound
(0.163 g, 6%).
The aldehyde (S)-6 was prepared from (S)-N,N-dibenz-
ylphenylglycinol (0.317 g, 1.00 mmol) as described in
4.1. A sample (ca. 50 mg) was withdrawn and immedi-
ately added to a mixture of NaBH4 (12 mg, 0.32 mmol)
and methanol (1 mL) cooled to 0°C. Then the aldehyde
was treated with NEt3 (34 mL, 0.24 mmol) and the
mixture was stirred at room temperature for 24 h.
Samples (ca. 50 mg) of this mixture were withdrawn
after 1, 2 and 3 h and reduced with NaBH4 at 0°C.
After derivatisation of the N,N-dibenzylphenylglycinols
with (S)-O-methylmandelic acid as described in Section
4.7.1. (1R,2S)-15. Colourless oil; [h]D=+42.1 (c=1.07,
ethyl acetate). IR (film): w=3061, 3028, 2960, 2910,
1
1
1726, 1494, 1452, 1246, 1025 cm−1; H NMR: l=7.78–
4.4.1. H NMR spectra in CDCl3 were taken. Integrals
7.71 (m, 2H), 7.54–7.20 (m, 18H), 6.34 (t, J=9.1 Hz,
1H, H-1), 4.58 (t, J=9.1 Hz, 1H, H-2), 4.17–3.83 (m,
4H), 3.95 (d, J=13.7 Hz, 2H), 3.23 (d, J=13.7 Hz,
2H), 1.15 (t, J=6.9 Hz, 3H), 1.10 (t, J=7.1 Hz, 3H);
13C NMR (75.5 MHz): l=165.13 (d, J=3.1 Hz, CꢁO),
139.14, 134.07 (d, J=10.9 Hz), 133.19, 129.77, 129.59,
129.38, 129.31, 128.36, 128.20, 127.98, 127.71,127.02,
67.92 (d, J=165.5 Hz, C-1), 62.89 (d, J=6.3 Hz), 62.84
(d, J=7.2 Hz), 62.79 (d, J=3.8 Hz, C-2), 54.64, 16.58
(d, J=6.0 Hz), 16.50 (d, J=6.0 Hz); 31P NMR: l=
19.80. Anal. calcd for C33H36NO5P: C, 71.08; H, 6.51;
N, 2.51. Found: C, 71.11; H, 6.26; N, 2.72%.
of signals at 4.714 and 4.695 ppm (H–C–OCH3) and at
3.366 and 3.334 ppm (CH3O–C–H) were selected for
calculation of e.e.
Acknowledgements
We thank Mrs. Jolanta Płocka for her skilled experi-
mental contributions. Financial support from the Medi-
cal University of Lo´dz (503-302-4) is gratefully
acknowledged.
4.7.2. (1S,2S)-10. Colourless oil; [h]D=+81.4 (c=1.88,
ethyl acetate). IR (film): w=3309, 3061, 3028, 2980,
References
1
2929, 1443, 1246, 1045, 1028 cm−1; H NMR: l=7.50–
1. Nicolaou, K. C.; Dai, W. M.; Guy, R. K. Angew. Chem.,
Int. Ed. Engl. 1994, 33, 15–44.
2. Lin, S.; Fang, K.; Hashimoto, M.; Nakanishi, K.; Ojima,
7.22 (m, 15H), 4.47 (dd, J=11.4 Hz, J=3.3 Hz, 1H,
H-2), 4.10 (dd, J=12.6 Hz, J=11.4 Hz, 1H, H-1), 3.91
(d, J=12.9 Hz, 2H), 3.88–3.75 (m, 3H), 3.66–3.52 (m,
1H), 3.07 (d, J=12.9 Hz, 2H), 0.95 (t, J=7.5 Hz, 3H),
0.93 (t, J=7.5 Hz, 3H); 13C NMR (75.5 MHz): l=
138.06, 132.72, 130.27, 129.26, 128.76, 128.42, 128.22,
127.61, 65.13 (d, J=173.6 Hz, C-1), 62.94 (d, J=3.8
Hz, C-2), 62.50 (d, J=6.0 Hz), 62.43 (d, J=7.5 Hz),
53.29, 16.32 (d, J=5.3 Hz), 16.24 (d, J=5.3 Hz); 31P
NMR: l=22.52. Anal. calcd for C26H32NO4P: C,
68.91; H, 7.11; N, 3.09. Found: C, 68.86; H, 7.16; N,
3.37%.
I. Tetrahedron Lett. 2000, 41, 4287–4290.
3. Mandai, T.; Kuroda, A.; Okumoto, H.; Nakanishi, K.;
Mikuni, K.; Hara, K.; Kara, K. Tetrahedron Lett. 2000,
41, 239–242.
4. Xue, M.; Long, B. H.; Fairchild, C.; Johnston, K.; Rose,
W. C.; Kadow, J. F.; Vyas, D. M.; Chen, S.-H. Bioorg.
Med. Chem. Lett. 2000, 10, 1327–1331.
5. Kingston, D. G. I.; Chordia, M. D.; Jagtap, P. G.; Liang,
J.; Shen, Y.-C.; Long, B. H.; Fairchild, C. R.; Johnston,
K. A. J. Org. Chem. 1999, 64, 1814–1822.
6. Ojima, I.; Wang, T.; Miller, M. L.; Lin, S.; Borella, C. P.;
Geng, X.; Pera, P.; Bernacki, R. J. Bioorg. Med. Chem.
Lett. 1999, 9, 3423–3428.
4.8. Hydrogenation of the phosphonates (1S,2S)-7 and
(1S,2S)-9
7. Yamaguchi, T.; Harada, N.; Ozaki, K.; Arakawa, H.;
Oda, K.; Nakanishi, N.; Tsujihara, K.; Hashiyama, T.
Bioorg. Med. Chem. Lett. 1999, 9, 1639–1644.
8. Lee, D.; Kim, M.-J. Tetrahedron Lett. 1998, 39, 2163–
2166.
9. Ojima, I.; Kuduk, S. D.; Pera, P.; Veith, J. M.; Bernacki,
R. J. J. Med. Chem. 1997, 40, 279–285.
10. Ojima, I.; Slater, J. C.; Kuduk, S. D.; Takeuchi, C. S.;
Gimi, R. H.; Sun, C.-M.; Park, Y. H.; Pera, P.; Veith, J.
M.; Bernacki, R. J. J. Med. Chem. 1997, 40, 267–278.
11. Ali, S. M.; Hoemann, M. Z.; Aube, J.; Georg, G. I.;
Mitscher, L. A.; Jayasinghe, L. R. J. Med. Chem. 1997,
40, 236–241.
The phosphonate (1S,2S)-7 (0.096 g, 0.225 mmol) was
dissolved in methanol (2 mL) containing (Boc)2O (0.049
g, 0.225 mmol) and hydrogenated over Pd(OH)2–C (20
mg). After filtration through a pad of Celite, methanol
was removed and the product was chromatographed on
silica gel with ethyl acetate–hexanes (2:1, v/v) to give
(1S,2S)-4 (R=Me) as a colourless oil (0.070 g, 91%).
[h]D=+22.4 (c=1.16, ethyl acetate). Anal. calcd for
C15H24NO6P: C, 52.17; H, 7.00; N, 4.06. Found: C,
52.26; H, 7.28; N, 3.77%.
Following the same procedure, using ethanol as a sol-
vent, from (1S,2S)-9 (0.065 g, 0.14 mmol) the phospho-
nate (1S,2S)-4 (R=Et) (0.047 g, 89%) was obtained as
a colourless oil. [h]D=+18.1 (c=0.91, ethyl acetate).
Anal. calcd for C17H28NO6P: C, 54.68; H, 7.56; N, 3.75.
Found: C, 54.57; H, 7.36; N, 3.58%.
12. Moyna, G.; Williams, H. J.; Scott, A. I. Synth. Commun.
1997, 27, 1561–1567.
13. Georg, G. I.; Harriman, G. C. B.; Hepperle, M.; Clowers,
J. S.; Vander Velde, D. G.; Himes, R. H. J. Org. Chem.
1996, 61, 2664–2676.